Intuitive Surgical, Inc. $ISRG Shares Bought by CreativeOne Wealth LLC

CreativeOne Wealth LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,472 shares of the medical equipment provider’s stock after acquiring an additional 486 shares during the quarter. CreativeOne Wealth LLC’s holdings in Intuitive Surgical were worth $2,710,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in ISRG. Brighton Jones LLC lifted its position in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after acquiring an additional 731 shares during the period. Bank Pictet & Cie Europe AG lifted its position in Intuitive Surgical by 0.5% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider’s stock worth $99,678,000 after acquiring an additional 883 shares during the period. AQR Capital Management LLC lifted its position in Intuitive Surgical by 14.9% during the 4th quarter. AQR Capital Management LLC now owns 33,592 shares of the medical equipment provider’s stock worth $17,534,000 after acquiring an additional 4,365 shares during the period. Voleon Capital Management LP acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $5,368,000. Finally, Kapitalo Investimentos Ltda acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $52,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $471.15 on Thursday. The stock has a fifty day moving average price of $501.89 and a 200 day moving average price of $519.66. The stock has a market cap of $168.90 billion, a PE ratio of 65.71, a P/E/G ratio of 4.97 and a beta of 1.59. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical’s revenue was up 21.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.78 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms have recently commented on ISRG. Royal Bank Of Canada reissued an “outperform” rating and issued a $615.00 price target on shares of Intuitive Surgical in a report on Tuesday, August 19th. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. UBS Group raised their price target on Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a report on Wednesday, July 23rd. Piper Sandler reissued an “overweight” rating and issued a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, July 26th. Thirteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $595.95.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president directly owned 907 shares of the company’s stock, valued at approximately $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Gary S. Guthart sold 7,893 shares of the firm’s stock in a transaction on Monday, July 28th. The stock was sold at an average price of $498.64, for a total value of $3,935,765.52. Following the transaction, the insider directly owned 13,187 shares of the company’s stock, valued at $6,575,565.68. The trade was a 37.44% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,839 shares of company stock valued at $7,896,972. 0.70% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.